Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
0.4389
+0.0290 (7.07%)
At close: Feb 27, 2026, 4:00 PM EST
0.4400
+0.0011 (0.25%)
After-hours: Feb 27, 2026, 7:59 PM EST

Autonomix Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22
Selling, General & Admin
10.016.565.251.2513.59
Research & Development
7.244.732.230.750
Other Operating Expenses
0.30.3---
Operating Expenses
17.5511.597.471.9913.59
Operating Income
-17.55-11.59-7.47-1.99-13.59
Interest Expense
-0.05-0.18-0.08--0.22
Interest & Investment Income
0.360.350.13--
Other Non Operating Income (Expenses)
---8-0.31
EBT Excluding Unusual Items
-17.24-11.41-15.43-1.99-13.5
Other Unusual Items
----0.17
Pretax Income
-17.24-11.41-15.43-1.99-13.33
Net Income
-17.24-11.41-15.43-1.99-13.33
Preferred Dividends & Other Adjustments
-----0.49
Net Income to Common
-17.24-11.41-15.43-1.99-12.84
Shares Outstanding (Basic)
52110
Shares Outstanding (Diluted)
52110
Shares Change (YoY)
269.85%69.73%73.12%480.20%-
EPS (Basic)
-3.40-6.46-14.82-3.31-123.94
EPS (Diluted)
-3.40-6.46-14.82-3.31-123.94
Free Cash Flow
-11.91-8.27-6.67-1.85-0.39
Free Cash Flow Per Share
-2.35-4.68-6.41-3.08-3.74
EBITDA
-17.49-11.41-7.39--
D&A For EBITDA
0.060.180.08--
EBIT
-17.55-11.59-7.47-1.99-13.59
Advertising Expenses
--1.8--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q